JPRN-UMIN000025639已完成未知
Microglia activity in various neuropsycholigical disorders - Microglia activity in various neuropsycholigical disorders
Tokyo Metropolitan Institute of Gerontology0 个研究点目标入组 20 人开始时间: 2017年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The subjects with a history of brain diseases, excluding than cerebellar diseases. 2. The subjects who are prescribed a medication for the central nervous system. 3. The subject who have chronic dysfunction in the organs. 4. Pregnant or woman who has a chance of pregnant. 5. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.
研究者
相似试验
已完成
不适用
Probing microglial activation in psychosis.'schizophrenia' 'psychosis'10039628NL-OMON39140niversitair Medisch Centrum Utrecht50
进行中（未招募）
1 期
Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using [18F]DPA-714pathology studied is schizophreniaMedDRA version: 20.0Level: PTClassification code: 10039626Term: Schizophrenia Class: 100000004873CTIS2023-504181-38-00Institut National De La Sante Et De La Recherche Medicale75
已完成
不适用
Imaging activated microglia in relapsing remitting multiple sclerosis: a first in human P2X7r PET studymultiple sclerosisNL-OMON47369Vrije Universiteit Medisch Centrum20
已完成
不适用
Microglial Activation in Inflammatory Bowel DiseaseMajor Depressive EpisodeInflammatory Bowel DiseasesNCT03487926Centre for Addiction and Mental Health40
已完成
不适用
Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of SchizophreniaSchizophreniaNCT02932605UMC Utrecht32